Blincyto

List of products in the National Drug Code with proprietary name blincyto. This medication is used to treat a certain type of cancer (acute lymphocytic leukemia-ALL). Blinatumomab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
55513-160Blincyto BlinatumomabKitAmgen IncHuman Prescription Drug